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Background: Although the quantification of health outcomes in a health impact assessment (HIA) is scarce in
practice, it is preferred by policymakers, as it assists various aspects of the decision-making process. This article
provides an example of integrating a quantitative risk appraisal in an HIA performed for the recently adopted
Hungarian anti-smoking policy which introduced a smoking ban in closed public places, workplaces and public
transport vehicles, and is one of the most effective measures to decrease smoking-related ill health. Methods:
A comprehensive, prospective HIA was conducted to map the full impact chain of the proposal. Causal
pathways were prioritized in a transparent process with special attention given to those pathways for
which measures of disease burden could be calculated for the baseline and predicted future scenarios.
Results: The proposal was found to decrease the prevalence of active and passive smoking and result in a
considerably positive effect on several diseases, among which lung cancer, chronic pulmonary diseases,
coronary heart diseases and stroke have the greatest importance. The health gain calculated for the quanti-
fiable health outcomes is close to 1700 deaths postponed and 16000 life years saved annually in Hungary.
Conclusion: The provision of smoke-free public places has an unambiguously positive impact on the health of
the public, especially in a country with a high burden of smoking-related diseases. The study described offers a
practical example of applying quantification in an HIA, thereby promoting its incorporation into political
decision making.
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Introduction
A health impact assessment (HIA) is a powerful tool used topredict the possible health effects of policies, programmes and
projects. The primary goal of an HIA is to assist policymakers and
thus to contribute to the strategy of health in all policies, although
the incorporation of an HIA in the decision-making process presents
challenges.1,2 In this article, the authors provide an example of using
epidemiological evidence and empirical data in a quantitative risk
assessment integrated in the HIA of the recently adopted Hungarian
anti-smoking policy.
A comprehensive HIA ideally integrates both qualitative and
quantitative evidence and methods.3 Solely qualitative assessments
dominate in practice, although quantitative estimates are favoured
by decision makers because they enable them to consider the size of
effects in terms of priority, to summarize positive and negative
impacts and to weigh the health effects against each other so as to
effectively assist the bargaining process.4 A quantitative assessment is
typically used to forecast health consequences due to environmental
exposures, for which methods borrowed from toxicology and envir-
onmental impact assessments can be applied.5 While the basic meth-
odological concepts to quantify health effects of non-environmental
factors in an HIA have been developed and are continuously refined,
few studies exist that apply epidemiological methods for the
prediction of health outcomes and integrate these methods in the
assessment process, especially in HIAs of policy proposals.3,4
Calculation of the disease burden is a feasible way to numerically
explain health gain in a combined measure.6
Tobacco use is one of the leading preventable causes of morbidity
and mortality worldwide. Diseases associated with smoking pose a
significant health burden on individuals, societies and health care
systems. Tobacco smoke exposure has been related to a wide range
of health effects.7,8 Smoking as a lifestyle factor affects not only
active smokers but also those who are in the vicinity of the
smoker via environmental tobacco smoke (ETS) exposure,
especially in indoor environments.9
There have been several initiatives made and programmes
launched worldwide to tackle the serious public health problem of
tobacco smoking. Both the Recommendation of the Council of the
European Union on smoke-free environments (2009/C 296/02) and
the Framework Convention on Tobacco Control (FCTC) of the
World Health Organization (WHO) aim to reduce smoking and
its health damaging effects.10 One of their major goals is the
protection of non-smokers from ETS exposure. The WHO’s
MPOWER package discusses the six available anti-smoking inter-
ventions among which tax increases, bans on advertising tobacco
products and prohibition of smoking in public places are reported
as the most effective measures.11,12
In the last decade, several countries have introduced comprehen-
sive anti-smoking policies. Hungarian political decision makers have
also realized the need for amending the existing anti-smoking legis-
lation by enacting a full restriction of smoking in indoor public
places. The demand was driven by the large amount of scientific
information and experience accumulated on the topic during the
last decade, as well as by the country’s international obligations.
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Hungary ratified FCTC and accepted the goals of the Green Paper of
the European Commission ‘Towards a Europe free from tobacco
smoke: policy options at EU level’.10,13 The special importance of
tightening anti-smoking policies is also underpinned by the high
prevalence of smoking and the large burden smoking-related
diseases pose on Hungarian society. In the last decade, premature
mortality due to lung cancer, chronic obstructive pulmonary
diseases, ischaemic heart diseases and stroke were 2.3–2.6, 2.5–4.6,
2.9–3.7 and 3.5–4.0 times higher, respectively, than the EU15
countries’ average according to the Health for All Database.14
In 2009, the strengthening political commitment had reached the
point at which a proposal was prepared for the amendment of the
existing Hungarian anti-smoking legislation that allowed the desig-
nation of smoking sites in most indoor public places as well as
smoking in catering facilities where no hot meals for local consump-
tion were served. As a basic rule, the proposal called for all indoor
public places to become non-smoking establishments, with very few
exceptions. It also placed a restriction on smoking in some open
public areas, such as playgrounds, underpasses and public transport
stations. The proposal was adopted by the Hungarian Parliament in
2011 and has been legally binding from 1 January 2012.
During the preparatory phase of the proposal, a need arose for the
assessment of its health effects, and an HIA incorporating the quan-
tification of several health outcomes was completed. Beyond
conducting a regular qualitative assessment, this study attempted
to prioritize causal pathways, identify those where quantification
was feasible and thus integrate a quantitative risk appraisal in the
HIA methodology.
Methods
A comprehensive, prospective HIA was performed in 2009–10 for
the proposed amendment of Act No. XLII of 1999 on the protection
of non-smokers and on certain rules of the consumption and trade
of tobacco products, commissioned by the Ministry of Health,
Hungary. The assessment used the broad model of health and
applied a range of public health and epidemiological methods
within a structural framework based on the Gothenburg consensus
paper. The original, qualitative work was completed with a
quantitative assessment within the framework of the EU-funded
‘Risk Assessment from Policy to Impact Dimension’ project.
The full causal chain of health impacts of the proposal was
mapped and analysed through the changes predicted at the level of
health determinants and risk factors to the direct health effects. The
health outcomes of primary importance were identified by the HIA
team in a transparent selection process. In the prioritization,
strength of evidence for causality, the severity and reversibility of
the condition as well as the frequency of occurrence in the
population, i.e. its public health importance, were taken into con-
sideration. Special attention was given to those health outcomes for
which both exposure and outcome assessments could be performed
in a quantitative manner.
Among the health determinants influenced by the proposal,
substance use and air quality were identified as the highest
priorities. In accordance, changes in the prevalence of active
smoking and in the pattern of ETS exposure were found to have a
primary importance at the risk factor level. A quantitative exposure
assessment could be carried out on the same impact pathways using
experiences from countries that had previously introduced similar
restrictions. A 7% reduction in the prevalence of active smoking, a
95% decrease in the prevalence of ETS exposure in the hospitality
sector, 70% in the workplace and 5.9% in households were used to
estimate the policy effect on exposures.15–19 The impact of decreased
passive smoking was considered only among non-smokers; for those
of them who were exposed to ETS in more than one location, the
location with the smallest reduction of exposure was applied. The
analysis of causal pathways found 17 diseases influenced by the
changing prevalence of active smoking and 4 diseases affected by
the reduction in ETS exposure in a quantifiable way.
Frequency measures of the quantifiable health outcomes were
taken from the most reliable sources. Age- and sex-specific demo-
graphic and mortality data were provided by the Central Statistical
Office. Morbidity data of circulatory system diseases were derived
from the General Practitioners Morbidity Sentinel Stations
Programme, morbidity data of cancer from the National Cancer
Registry and of chronic respiratory diseases from the Koranyi
National Institute for Tuberculosis and Pulmonology.20 Age- and
sex-specific exposure data (prevalence of active and passive
smoking at various sites) were provided by the 2005–06 study on
the aetiology of chronic liver disease by the School of Public Health,
University of Debrecen, which collected information on the smoking
habits and on the daily time spent indoors with ETS exposure at the
workplace, at home or during spare time activities. Passive smoking
status was established when at least one minute’s ETS exposure was
indicated. As all required data were available for 2006, this year was
chosen to calculate the baseline values.
Association measures were acquired from the literature. In the
selection process of sources, preference was given to relative risks
(RRs) provided by meta-analyses and large-scale cohort studies.
Regarding active smoking, RRs for neoplastic diseases were used
from the meta-analysis by Gandini carried out on 216 studies
and RRs for circulatory and respiratory diseases from Thun who
analysed the results of the nationwide prospective Cancer
Prevention Study II of nearly one million US adults.21,22 In the
case of passive smoking, different association measures were
applied for ETS exposure suffered during spare time activities, at
the workplace, and at home. RR values for lung cancer were acquired
from Zhong and Boffetta and for coronary heart disease from He,
Wells and Thun.23–27 Association measures for stroke were taken
from Lee and Bonita and for chronic pulmonary disease from
Eisner.28–30
For the quantifiable diseases, age- and sex-specific population at-
tributable risk fractions (PAFs) were determined using exposure data
and association measures. To calculate attributable death and
disability-adjusted life years (DALYs) as the sum of the potential
years of life lost (PYLL) and the years of life lived with disability
(YLD), the methodology applied by the WHO in the Global Burden
of Disease 2004 study was used.31 PYLL were determined using age-
and sex-specific Hungarian life expectancies for 2006. To calculate
YLD, the WHO age-specific disability weights for treated cases were
applied. The DisMod II software (version 1.01) provided by the
WHO was used to estimate the average duration lived with a
disease, as these data were not readily available. Cause-, age- and
sex-specific incidence, prevalence and mortality rates, as well as age-
and sex-specific population numbers and mortality rates, served as
input variables for DisMod computation. In the calculation of
DALY, the standard 3% discount rate and the standard age
weights (= 0.04, C = 0.1658) were used as proposed by Murray.6
The average annual disease burden was calculated for the baseline
year of 2006 and for the predicted future situation that is expected
within two decades after the full smoking ban in closed public places
became effective in 2012. It is reported that 20 years after cessation
the risk of all major smoking-related diseases decreases to the
normal level, except that of lung cancer; however, that is significantly
reduced, too.32,33 The difference of disease burden between the
baseline and the predicted future scenario was considered to be
the health gain of the proposal.
Univariate sensitivity analysis was performed to characterize how
sensitive the impact estimates are to the uncertainty of various input
variables. The analysis included the policy effect on exposure using
the lowest and highest values published in the literature as well as the
association measures and exposure prevalence estimates with their
reported 95% confidence intervals. The influence of discounting and
age-weighting on the outcome was also assessed.
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Based on the model applied, the disease burden of active smoking
for the quantifiable health outcomes is 15 097 attributable deaths
and 162 766 DALYs in 2006. The burden of passive smoking is
about one order of magnitude lower (1852 deaths and 17 307
DALYs). The new regulation is expected to reduce the combined
annual burden of active and passive smoking by 9.9% of attributable
deaths (1685 deaths) and 8.9% of DALYs (15 986 life years) in the
long term in the Hungarian population of 10 million people due to
avoiding early mortality and disabled living. Reduced ETS exposure
has a larger contribution to the overall impact than the decreased
prevalence of active smoking. This observation is true for both
measures; the health gain is 633 and 1052 attributable deaths as
well as 6068 and 9918 DALYs related to active and passive
smoking, respectively.
The highest disease burden associated with active smoking was
calculated for lung cancer (ICD C33-34), chronic respiratory
diseases (J40-44), coronary heart diseases (I20-25), stroke (I60-69)
and arterial diseases other than heart and cerebrovascular diseases
(I70-78). The disease burden of all neoplastic diseases other than
lung cancer attributable to active smoking was approximately one
order of magnitude smaller.
Figure 1 illustrates the decreased number of attributable deaths
due to the expected fall in the prevalence of active smoking. The
largest reduction in attributable death was estimated for coronary
heart diseases, followed by lung cancer, stroke and pulmonary
diseases. The effect was found to be larger in males for all
quantified diseases, the gender difference is especially pronounced
in malignancies other than lung cancer. Expressing disease burden in
DALY, the most significant health benefit is identified for coronary
heart diseases, followed by lung cancer and chronic pulmonary
diseases (figure 2). The male dominance remains but the gender
difference is smaller, e.g. for chronic pulmonary diseases it almost
disappears.
The forecasted reduction in the frequency of ETS exposure in
hospitality venues, workplaces and households was predicted to
have the largest effect on circulatory disease mortality. Stroke and
coronary heart diseases were determined to have the greatest
decrease in attributable death, followed by much smaller
reductions for lung cancer and chronic pulmonary diseases
(figure 3). Males contribute with a considerably larger share to the
reduction seen for lung cancer and pulmonary diseases, but the
gender difference decreases for coronary heart diseases, and even
reverses for stroke. When expressing the disease burden in DALY,
the highest decrease was found for coronary heart diseases and
stroke, too (figure 3). The contributions of chronic pulmonary
diseases and lung cancer to the reduction in DALY are approxi-
mately half and one-third of that of circulatory diseases. The
sex-specificity of effects is similar to that observed for attributable
deaths with the exception of pulmonary diseases where share of
females is increased and of stroke that is observed with equal con-
tribution of genders.
Sensitivity analysis reveals a significant, close to 70% increase
in the estimated overall effect of the proposal when neither
discounting nor age-weighting are applied in the calculation of
Figure 1 The reduction in attributable death of high-burden (A) and other diseases (B) caused by the predicted decrease in the prevalence
of active smoking, expected within two decades after the introduction of the full smoking ban in closed public places in Hungary
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DALY (table 1). The policy effect on exposure shows a limited
impact towards the lower limit and a larger influence on the
upper limit that reflects the conservative nature of our point
estimates. The highest uncertainty is related to the association
measures that have around 40% impact on either side, while the
uncertainty of the exposure estimates has a smaller contribution to
the uncertainty of the outcome, especially on the lower limit.
Discussion
Our results revealed a sizable disease burden of active and passive
smoking in Hungary. There are very few studies that quantitatively
assess smoking-related burden in the country, and those that exist
typically analyse only mortality data and related expenses. The GKI
Economic Research Institute calculated 123 538 lost years of life due
to active smoking for 1998.34 We estimated a similar disease burden
in 2006 when 118 155 life years were lost in Hungary as a conse-
quence of early deaths due to selected smoking-related diseases. The
benefit of the prohibition of smoking in public places calculated only
for the quantifiable health outcomes was found to be close to 1700
deaths postponed and 16 000 life years saved annually in the long
term in Hungary, for which decreasing ETS exposure has a stronger
contribution than the reduction in smoking prevalence. The size of
the effect is larger among males than among females.
Observations from other countries were used to estimate exposure
change; although limitations in extrapolating data from one society
to another must be acknowledged. Professional consensus on the
information sources used in the model was reached via two
principal considerations: cultural similarities between societies and
precaution, i.e. giving greater weight to lower reductions in exposure
levels reported by various sources. This intention is justified by the
sensitivity analysis that indicates a small negative influence of the
inputted policy effect size on the output measures of the impact
assessment.
The findings in this study are comparable to those in the literature
that examine the short-term effects of smoking restrictions on acute
circulatory events. Meyers et al.35 conducted a systematic review and
meta-analysis of studies dealing with decreased hospital admissions
for acute myocardial infarction (AMI) after the introduction of a
smoking ban. The authors found 11 reports from 10 study
locations and concluded that there was a 17% overall risk
reduction. Significant improvement of respiratory and sensory
symptoms was similarly observed among hospitality workers in
Scotland and elsewhere.36 Unfortunately, there has not yet been sub-
stantial evidence to make comparisons of the other chronic health
effects analysed in this article.
Tobacco control policies impact the genders differently. Policy
measures can have dissimilar influence on the genders as seen in
the school-based prevention of substance misuse, or in the taxation
of tobacco products.37,38 Other determinants of sex-specific impact
are the differing exposure patterns, age-specific morbidity and
mortality rates and strengths of association between exposures and
outcomes. Our results revealed gender differences in the impact of
the analysed Hungarian smoking ban, too. The absolute size of effect
was found larger in males than in females (1031 vs. 654 attributable
deaths and 9939 vs. 6047 DALYs, respectively) but the rate of
Figure 2 The reduction in DALYs of high-burden (A) and other diseases (B) caused by the predicted decrease in the prevalence of active
smoking, expected within two decades after the introduction of the full smoking ban in closed public places in Hungary
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reduction was more pronounced in females than in males (13.5 vs.
8.5% decrease in attributable deaths and 10.1 vs. 8.3% in DALYs,
respectively).
The burden of disease model applied in this study has an essen-
tially static nature assuming a baseline scenario with constant
exposure rates and ignored long-term health effects of past
changes in smoking. It is unable to follow the health impact over
time; however, observations made by Kabir et al.39 indicate that
there is a 20- to 30-year time lag between the reduction of to-
bacco consumption due to the introduction of anti-smoking
policies and the observed effects on lung cancer outcomes.
Therefore, the predictions of this study can be expected to
occur in 15–20 years, taking into consideration the more rapid
effects on non-neoplastic diseases, too. A dynamic model
could simulate the effects of past exposure trends. The
DYNAMO-HIA software, which was published after the
completion of this study, provides a promising tool for dynamic
modelling.40
Quantitative estimates are favoured by decision makers, in spite of
the disadvantages, such as hiding complexity, the potential for
double counting, obscured uncertainty and the limited possibility
of a participatory approach. The effective assistance of the political
process promotes the integration of HIA with quantitative predic-
tions in political decision making. The presented HIA has also been
welcomed by policy makers but was not acted upon due to the
approaching parliamentary elections in 2010. The new government
revived the issue and the amendment of the policy was adopted in
2011. Despite the uncertainties regarding the extrapolation of policy
effect size on exposure levels from one society to another, the
Figure 3 The reduction in attributable death (A) and DALYs (B) caused by the predicted decrease in the prevalence of ETS exposure in
hospitality venues, at workplaces and in households, expected within two decades after the introduction of the full smoking ban in closed
public places in Hungary
Table 1 Sensitivity analysis of the predicted health impact of the





Three percent discounting, no age-weighting 137
No discounting and age-weighting 169
Policy effect on exposure
Lower limit 91 92
Upper limit 134 136
Association measure
Lower limit 63 63
Upper limit 146 145
Exposure prevalence
Lower limit 82 84
Upper limit 143 126
Alternative results are expressed as the percentage of the corres-
ponding point estimate
Analysis of novel smoke-free policy in Hungary 215






estimation of the average duration lived with a disease in a DisMod
model, as well as the limitations of the static model as mentioned
above, the presented methodology offers a practical approach for a
quantitative risk appraisal in the HIA.
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Key points
 This article presents an example for how to use epidemiolo-
gical evidence and empirical information to quantitatively
assess the impact of the recently approved Hungarian
smoke-free policy on a broad range of health outcomes for
which quantification is feasible.
 The long term health benefit of the prohibition of smoking
in closed public places is significant in Hungary. The effect
of decreasing ETS exposure is larger than that induced
by the reduction in the prevalence of active smoking. The
absolute impact is higher among males than among females.
 The integration of a quantitative assessment in the process of
a HIA allows for numerical predictions that effectively assist
the bargaining process and thus facilitate the use of HIA
results in political decision making.
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Background: We aimed to quantify the number of women and men, in Catalonia, among those not achieving
physical activity recommendations, making short motorized trips which could have been made on foot, and to
estimate the annual economic benefit due to reducing mortality as a result of replacing one short, daily,
motorized journey with walking. Methods: Cross-sectional study. Mobility data came from individuals >17 years
who reported, in the 2006 Daily Mobility Survey, having travelled on the referred working day (N=80 552). The
health economic assessment tool for walking (HEAT) from the World Health Organization (WHO) Regional Office
for Europe was used to calculate the economic benefit. Results: Of those not meeting recommendations, 15.6% of
men (95% CI 15.2–16.1) and 13.9% of women (95% CI 13.5–14.4) would go on to meet them if they were to
replace at least one short motorized trip per day by walking. If applied to the entire population of Catalonia, this
change would increase up to 326557 men (95% CI 313 373–339740) and up to 252509 women (95% CI 240 855–
264 163) who would achieve recommendations through walking rather than driving. According to HEAT estima-
tions, this would suppose a saving of E124216000 (95% CI 120 182 000–128250000) in men and E84 927000 (95%
CI 81774 000–88 079000) in women, derived from the reduction in mortality gained from walking accumulated
over one year. Conclusion: This study demonstrates the potential of trips on foot as a source of physical activity. It
also points out that both benefits for the health of the population and a huge economic benefit could have been
gained through active transportation interventions.
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Introduction
There is evidence that a sedentary lifestyle contributes to thedecline in health at different levels1 and that physical activity is
essential to maintain good health.2,3 Moreover, the World Health
Organization (WHO), through the Global Strategy on Diet, Physical
Activity and Health, concluded in 2004,4 and confirmed in 2010,
that at least 150 minutes of moderate-intensity aerobic physical
activity undertaken throughout the week is sufficient in adults,
aged 18–65 years.5
Walking as a means of transport is considered a moderate physical
activity, suitable for achieving recommended activity levels.
Despite its numerous reported health benefits6 walking has mainly
been studied as a leisure time activity, while most studies of
mobility conducted in Spain or Europe have been undertaken by
the transport sector,7–9 with the aim of planning motorized
transport.
However, in recent years strategies attempting to integrate active
transport into daily life have gathered force in many countries,
promoted by the global strategies developed by the WHO,10 or the
Centers for Disease Control and Prevention (CDC).11 Promotion of
the use of active transport is seen as a tool to combat the trend of
increasing sedentarism in the population.12 This has also been
proposed by the new WHO Action Plan for the implementation
of the European Strategy for the Prevention of Noncommunicable
Diseases 2012/2016,13 which identifies the promotion of
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